In finding that Sandoz and RareGen failed to demonstrate they were likely to prevail in the litigation, the Court noted that Sandoz and RareGen "produced no evidence UTC's purchase of [the cartridges ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, a leading global medical device manufacturer, announced today it has received FDA 510(k) clearance to market its CADD ®-Solis pain management system ...